Hydroxyl-alpha-sanshool lipid microbubble as well as preparation method and application thereof

Through the modification of polyethylene glycol modification and hollow vesicle structure design of modified phospholipid anchors, combined with fluorine-containing inert gas, the problems of low encapsulation rate and slow release of hydroxy-α-mountain liposomes are solved, achieving high The encapsulation rate and rapid release effect improve their stability and use effect in clinical applications.

CN118986881APending Publication Date: 2024-11-22DIMENG TECH (GUANGDONG) CO LTD
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202411099278.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-12
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

In the prior art, the encapsulation rate of hydroxy-α-masaicin liposomes is low, unable to release promptly and quickly, and poor cell affinity, which limits its use scenarios in clinical applications.

Method used

Use modified phospholipid-anchored polyethylene glycol to modify the lipid shell, design the hollow vesicle structure, combine fluorine-containing inert gas and specific lipid auxiliary materials, and improve the encapsulation rate and stability of hydroxy-α-yransaicin lipid microvesicles and its dispersion and stability in water are enhanced by the preparation method of modified polyethylene glycol.

Benefits of technology

The high encapsulation rate, stability and rapid release effect of hydroxy-α-beansaicin lipid microvesicles is achieved, and its use effect and stability in clinical applications are improved.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The invention relates to the field of pharmaceutical preparations, in particular to a hydroxyl-alpha-sanshool lipid microbubble as well as a preparation method and application of the hydroxyl-alpha-sanshool lipid microbubble. Comprising the following raw materials: 8-12 parts of hydroxyl-alpha-sanshool, 35-45 parts of a lipid auxiliary material, 5-10 parts of cholesterol, 7-10 parts of modified phospholipid anchored polyethylene glycol, 20-22 parts of fluorine-containing inert gas, 70-110 parts of a solvent and 120-220 parts of distilled water. The hydroxyl-alpha-sanshool lipid microbubble prepared by the invention has the advantages of high encapsulation efficiency, good stability, good dispersibility and the like, and has a slow release effect, and the addition amount of the hydroxyl-alpha-sanshool lipid microbubble applied to an external delay spray is 0.2-0.4 wt%.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of pharmaceutical preparations, and in particular to hydroxy-alpha-sanshool lipid microbubbles and a preparation method and application thereof. Background Art

[0002] Hydroxy-α-sanshool is an unsaturated chain fatty acid amide, which is an important material basis for the special spicy taste of pepper. Hydroxy-α-sanshool can resist ultraviolet rays, remove excessive reactive oxygen free radicals, and has antimicrobial, inflammation regulation, and neuroprotective effects. Therefore, hydroxy-α-sanshool can be used to prepare drugs and has great potential in clinical applications. However, hydroxy-α-sanshool contains double bond groups with high activity, is easily inactivated under various conditions such as light and heat, and has poor stability. When it is prepared into drugs, it will bring great challenges to storage and application. At present, preparing hydroxy-α-sanshool into liposomes is conducive to solving the problem of poor stability of hydroxy-α-sanshool.

[0003] Liposomes are composed of phospholipid molecules, the polar part of which tends to be close to the water phase, while the non-polar part tends to be far away from the water phase, so that liposomes can be dispersed in water. Using lipid materials to encapsulate drugs to form liposomes can improve the stability of drugs, and phospholipids can easily fuse with cell membranes to deliver drugs into cells, improving the effectiveness of drugs. However, the biggest problem with liposomes is the low encapsulation rate, which can lead to drug loss.

[0004] Patent CN113975234A discloses a hydroxy-α-sanshool nanoliposome and a preparation method thereof. Hydroxy-α-sanshool nanoliposome and lipid excipients are dissolved in an organic solvent to obtain a film, which is then added to a hydrating medium for hydration, and finally purified to obtain hydroxy-α-sanshool nanoliposome. The liposome has the characteristics of uniform dispersion, good stability and high safety, but the liposome cannot achieve the effect of timely and rapid release of hydroxy-α-sanshool, which limits its use scenarios.

[0005] Patent CN113816870A discloses a hydroxy-α-sanshool nanostructure lipid carrier and a preparation method thereof. Hydroxy-α-sanshool, glyceryl monostearate, oleic acid and a solvent are blended to obtain an oil phase, and then poloxamer 188 is heated and dissolved to obtain an aqueous phase. The aqueous phase is dropped into the oil phase under stirring conditions, and stirred evenly to obtain a coarse dispersion. Finally, the hydroxy-α-sanshool nanostructure lipid carrier is obtained by ultrasonic treatment. The stability of the hydroxy-α-sanshool is ensured, and at the same time, a good analgesic effect can be achieved through sustained release. However, the affinity of the liposome to cells is poor.

[0006] Therefore, there is an urgent need in the market for a hydroxy-α-sanshool lipid microbubble with high encapsulation rate, timely release and good cell affinity. Summary of the invention

[0007] In view of the problems existing in the prior art, the purpose of the present invention is to obtain hydroxy-α-sanshool lipid microbubbles which have high encapsulation efficiency, high stability, good dispersibility in water, and can release drugs in a timely and rapid manner.

[0008] In order to achieve the above object, the technical solution adopted by the present invention is as follows:

[0009] The first aspect of the present invention provides a hydroxy-α-sanshool lipid microbubble, which comprises the following raw materials, in parts by weight: 8-12 parts of hydroxy-α-sanshool, 35-45 parts of lipid auxiliary materials, 5-10 parts of cholesterol, 7-10 parts of modified phospholipid-anchored polyethylene glycol, 20-22 parts of fluorine-containing inert gas, 70-110 parts of solvent, and 120-220 parts of distilled water.

[0010] The present application uses lipid excipients, cholesterol, and hydroxy-α-sanshool to prepare lipid microbubbles, and uses modified phospholipid-anchored polyethylene glycol to modify the lipid shell. In such lipid microbubbles, hydroxy-α-sanshool is embedded in the liposomes, and the hydrophilic groups on the lipid microbubbles and the hydrophilic segments on the modified phospholipid-anchored polyethylene glycol, as well as the amide groups and hydroxyl hydrophilic groups on the hydroxy-α-sanshool are exposed in water, which promotes the dispersion of the hydroxy-α-sanshool liposomes, so that the obtained hydroxy-α-sanshool liposomes have the advantages of high encapsulation rate, high stability, good dispersibility, etc. In addition, the present application designs the liposomes into a hollow vesicle structure so that the hydroxy-α-sanshool lipid microbubbles are more likely to rupture in some application scenarios, and the effect of rapid release of hydroxy-α-sanshool can be achieved.

[0011] In some embodiments, the lipid excipient is one or more of soybean lecithin, distearoylphosphatidylethanolamine, and dipalmitoylphosphatidylethanolamine.

[0012] Preferably, the lipid excipient is soy lecithin.

[0013] In some embodiments, the method for preparing the modified phospholipid-anchored polyethylene glycol comprises the following steps:

[0014] A1. Add ethylene oxide, bis(2-hydroxyethyl)amino(trihydroxymethyl)methane, a catalyst and a solvent into a reaction vessel, react at 10-20°C for 3-4h, raise the temperature to 35-45°C, continue to react for 4-8h, evaporate the solvent and add it into anhydrous ether, filter and dry the precipitate to obtain modified polyethylene glycol;

[0015] A2, adding the modified polyethylene glycol and toluene obtained in step A1 to a reaction vessel, stirring at room temperature for 20-30 min, adding carbonyldiimidazole, distearoylphosphatidylethanolamine and 4-dimethylaminopyridine, reacting at 55-65° C. for 6-7 h, rotary evaporating the solvent and adding to anhydrous ether, filtering and drying the precipitate to obtain phospholipid-anchored modified polyethylene glycol;

[0016] A3. Add the phospholipid-anchored modified polyethylene glycol obtained in step A2, 1-bromopropane, ethyl acetate, N,N-dimethylformamide and 4-dimethylaminopyridine into a reaction vessel, heat to 70-90° C. and react for 5-7 hours. After the solvent is evaporated, add the mixture into anhydrous ether. Filter and dry the precipitate to obtain the modified phospholipid-anchored polyethylene glycol.

[0017] The present application adds bis(2-hydroxyethyl)amino(trihydroxymethyl)methane during the synthesis of polyethylene glycol, thereby introducing a quaternary ammonium salt group with good water solubility and positive charge, which can further improve the dispersibility of hydroxy-α-sanshool lipid microbubbles in water; on the other hand, the introduction of a side chain structure containing hydroxyl groups can enhance the interaction between the substances through hydrogen bonding and improve the stability of the liposome microbubbles.

[0018] In some embodiments, the number average molecular weight of the modified phospholipid-anchored polyethylene glycol is 1500-2500.

[0019] The present application limits the molecular weight of the modified phospholipid-anchored polyethylene glycol, thereby ensuring that the modified phospholipid-anchored polyethylene glycol has good emulsifying properties and can form a layer of three-dimensional brush on the liposome microbubbles through a load with good amphiphilic properties after the liposome microbubbles are formed, thereby inhibiting the fusion of microbubbles through spatial repulsion and improving the yield of microbubbles.

[0020] In some embodiments, the mass ratio of ethylene oxide to bis(2-hydroxyethyl)amino(trihydroxymethyl)methane is 1:(0.15-0.2).

[0021] In some embodiments, the mass ratio of the phospholipid-anchored modified polyethylene glycol to 1-bromopropane in step A3 is 1:(0.04-0.08).

[0022] The hydroxyl-containing side chain structure and quaternary ammonium salt group on polyethylene glycol will make the modified phospholipid-anchored polyethylene glycol more hydrophilic and hinder the formation of three-dimensional brushes. The present application selects a specific ratio of bis(2-hydroxyethyl)amino(trihydroxymethyl)methane as a modifier and limits the ratio of phospholipid-anchored modified polyethylene glycol and 1-bromopropane, so that the modified polyethylene glycol has better loading performance while having better dispersion performance.

[0023] The second aspect of the present invention provides a method for preparing hydroxy-α-sanshool lipid microbubbles, comprising the following steps:

[0024] B1, dissolving hydroxy-α-sanshool, lipid auxiliary material and cholesterol in a solvent to obtain an oil phase;

[0025] B2, dissolving the modified phospholipid-anchored polyethylene glycol in distilled water to obtain an aqueous phase;

[0026] B3, the oil phase obtained in step B1 and the water phase obtained in step B2 are mixed, stirred at room temperature for 60-100 minutes, and then a fluorine-containing inert gas is introduced, and hydroxy-α-sanshool lipid microbubbles are obtained after washing and drying.

[0027] In some embodiments, the mass ratio of the water phase to the oil phase in step B3 is 1:(0.5-0.7).

[0028] The present application can promote the formation of an oil-in-water system by limiting the ratio of the water phase to the oil phase, thereby improving the encapsulation rate of the hydroxy-α-sanshool lipid microbubbles.

[0029] In some embodiments, the fluorine-containing inert gas is one or more of sulfur hexafluoride, perfluoroethane, and perfluoropropane.

[0030] Preferably, the inert gas is perfluoropropane.

[0031] The present application prepares hydroxy-α-sanshool lipid microbubbles by selecting fluorine-containing inert gas, which can make the weight of the microbubbles relatively high and easier to suspend in water, so that the drug content in each part of the preparation is uniform and stable, thereby improving the use effect of the drug.

[0032] The third aspect of the present invention provides an application of hydroxy-α-sanshool lipid microbubbles, wherein the addition amount of the hydroxy-α-sanshool lipid microbubbles to the external delayed spray is 0.2-0.4wt%.

[0033] The hydroxy-α-sanshool lipid microbubbles prepared in the present application can be used for external delayed sprays. During transportation and storage, the hydroxy-α-sanshool lipid microbubbles can exert their sustained-release effect to ensure the stability of hydroxy-α-sanshool, and the pressure when the spray is sprayed out can promote the rupture of the hydroxy-α-sanshool lipid microbubbles, so that the hydroxy-α-sanshool can exert an immediate effect.

[0034] Compared with the prior art, the present invention has the following beneficial effects:

[0035] (1) The present invention uses lipid excipients, cholesterol, and hydroxy-α-sanshool to prepare liposomes, and uses modified phospholipid-anchored polyethylene glycol to modify the lipid shell, so that the hydroxy-α-sanshool liposomes have the advantages of high encapsulation rate, high stability, good dispersibility, etc., and the present application designs the liposomes into a hollow vesicle structure so that the hydroxy-α-sanshool lipid microbubbles are easier to rupture in some application scenarios, thereby achieving the effect of rapid release of hydroxy-α-sanshool.

[0036] (2) The present invention introduces a tertiary amine group by using bis(2-hydroxyethyl)amino(trihydroxymethyl)methane-modified polyethylene glycol, and reacts it with an alkyl halide to generate a quaternary ammonium salt group. On the one hand, a quaternary ammonium salt group with good water solubility and positive charge is introduced, which can further improve the dispersibility of hydroxy-α-sanshool lipid microbubbles in water; on the other hand, the introduction of a branched structure containing hydroxyl groups can enhance the interaction between various substances through hydrogen bonding and improve the stability of liposome microbubbles. And by limiting the molecular weight of the modified phospholipid-anchored polyethylene glycol, the modified phospholipid-anchored polyethylene glycol can form a layer of three-dimensional brush on the liposome microbubbles while having good emulsification properties, inhibit the fusion of microbubbles through spatial repulsion, and improve the yield of microbubbles.

[0037] (3) The present invention selects fluorine-containing inert gas to prepare hydroxy-α-sanshool lipid microbubbles, which can make the weight of the microbubbles relatively high and easier to suspend in water, so that the drug content in each part of the preparation is uniform, thereby improving the use effect of the drug. DETAILED DESCRIPTION

[0038] The present invention will be described below in conjunction with specific embodiments. It should be noted that the following embodiments are examples of the present invention and are only used to illustrate the present invention, but not to limit the present invention. Other combinations and various modifications within the concept of the present invention may be performed without departing from the spirit or scope of the present invention.

[0039] In the following examples and comparative examples, except for the modified phospholipid-anchored polyethylene glycol, the other compounds and related reagents used can be purchased from the market, among which polyethylene glycol monomethyl ether-2000-dioctadecylphosphatidylethanolamine was purchased from Beijing Mairida Technology Co., Ltd.

[0040] Preparation Example 1

[0041] The preparation method of modified phospholipid-anchored polyethylene glycol-1 comprises the following steps:

[0042] A1. Add 10 g of ethylene oxide, 1.7 g of bis(2-hydroxyethyl)amino(trihydroxymethyl)methane, 0.1 g of aluminum isopropoxide and 20 g of distilled water into a reaction vessel, react at 15° C. for 3.5 h, heat to 40° C., continue to react for 6 h, evaporate the distilled water and add it to 15 g of anhydrous ether, filter and dry the precipitate to obtain modified polyethylene glycol;

[0043] A2, add 10g of the modified polyethylene glycol obtained in step A1 and 15g of toluene to a reaction container, stir at room temperature for 25min, add 0.82g of carbonyldiimidazole, 3.7g of distearoylphosphatidylethanolamine and 0.31g of 4-dimethylaminopyridine, react at 60°C for 6.5h, evaporate the solvent and add to 20g of anhydrous ether, filter and dry the precipitate to obtain phospholipid-anchored modified polyethylene glycol;

[0044] A3. Add 10 g of the phospholipid-anchored modified polyethylene glycol obtained in step A2, 0.6 g of 1-bromopropane, 10 g of ethyl acetate, 5 g of N,N-dimethylformamide and 0.1 g of 4-dimethylaminopyridine to a reaction vessel, heat to 80 ° C for reaction, evaporate the solvent and add to 15 g of anhydrous ether, filter and dry the precipitate to obtain modified phospholipid-anchored polyethylene glycol-1 with a number average molecular weight of 2000.

[0045] Preparation Example 2

[0046] The preparation method of modified phospholipid-anchored polyethylene glycol-2 is the same as that of Preparation Example 1, except that the added amount of bis(2-hydroxyethyl)amino(trihydroxymethyl)methane is 2.2 g.

[0047] Preparation Example 3

[0048] The preparation method of modified phospholipid-anchored polyethylene glycol-3 is the same as that of Preparation Example 1, except that the amount of 1-bromopropane added is 1 g.

[0049] Preparation Example 4

[0050] The preparation method of modified phospholipid-anchored polyethylene glycol-4 is the same as that of Preparation Example 1, except that the number average molecular weight of the modified phospholipid-anchored polyethylene glycol-4 is 3500.

[0051] Example 1

[0052] The invention discloses a hydroxy-α-sanshool lipid microbubble, which comprises the following raw materials in parts by weight: 10 parts of hydroxy-α-sanshool, 40 parts of soybean lecithin, 7 parts of cholesterol, 8 parts of polyethylene glycol-1 anchored by modified phospholipids, 21 parts of perfluoropropane, 90 parts of chloroform and 170 parts of distilled water.

[0053] The preparation method of hydroxy-α-sanshool lipid microbubbles of the present embodiment comprises the following steps:

[0054] B1, dissolving hydroxy-α-sanshool, soybean lecithin and cholesterol in chloroform to obtain an oil phase;

[0055] B2, dissolving the modified phospholipid-anchored polyethylene glycol-1 in distilled water to obtain an aqueous phase;

[0056] B3, the oil phase obtained in step B1 and the water phase obtained in step B2 are mixed, and perfluoropropane is introduced after stirring at room temperature for 80 minutes, and hydroxy-α-sanshool lipid microbubbles are obtained after washing and drying.

[0057] The mass ratio of the water phase to the oil phase in step B3 is 1:0.7.

[0058] Example 2

[0059] A hydroxy-α-sanshool lipid microbubble comprises the following raw materials, measured in parts by weight: 8 parts of hydroxy-α-sanshool, 35 parts of lipid auxiliary materials, 5 parts of cholesterol, 7 parts of modified phospholipid-anchored polyethylene glycol-1, 20 parts of perfluoropropane, 70 parts of chloroform and 120 parts of distilled water.

[0060] The preparation method of hydroxy-α-sanshool lipid microbubbles of the present embodiment comprises the following steps:

[0061] B1, dissolving hydroxy-α-sanshool, soybean lecithin and cholesterol in chloroform to obtain an oil phase;

[0062] B2, dissolving the modified phospholipid-anchored polyethylene glycol-1 in distilled water to obtain an aqueous phase;

[0063] B3, the oil phase obtained in step B1 and the water phase obtained in step B2 are mixed, and perfluoropropane is introduced after stirring at room temperature for 60 minutes, and hydroxy-α-sanshool lipid microbubbles are obtained after washing and drying.

[0064] The mass ratio of the water phase to the oil phase in step B3 is 1:0.5.

[0065] Example 3

[0066] A hydroxy-α-sanshool lipid microbubble comprises the following raw materials, measured in parts by weight: 12 parts of hydroxy-α-sanshool, 45 parts of lipid auxiliary materials, 10 parts of cholesterol, 10 parts of modified phospholipid-anchored polyethylene glycol-1, 22 parts of perfluoropropane, 110 parts of chloroform and 220 parts of distilled water.

[0067] The preparation method of hydroxy-α-sanshool lipid microbubbles of the present embodiment comprises the following steps:

[0068] B1, dissolving hydroxy-α-sanshool, soybean lecithin and cholesterol in chloroform to obtain an oil phase;

[0069] B2, dissolving the modified phospholipid-anchored polyethylene glycol-1 in distilled water to obtain an aqueous phase;

[0070] B3, the oil phase obtained in step B1 and the water phase obtained in step B2 are mixed, and perfluoropropane is introduced after stirring at room temperature for 100 minutes, and hydroxy-α-sanshool lipid microbubbles are obtained after washing and drying.

[0071] The mass ratio of the water phase to the oil phase in step B3 is 1:0.9.

[0072] Example 4

[0073] A hydroxy-α-sanshool lipid microbubble and a preparation method thereof. The specific implementation manner is the same as that of Example 1, except that an equal amount of modified phospholipid-anchored polyethylene glycol-1 is replaced by modified phospholipid-anchored polyethylene glycol-2.

[0074] Example 5

[0075] A hydroxy-α-sanshool lipid microbubble and a preparation method thereof. The specific implementation manner is the same as that of Example 1, except that an equal amount of modified phospholipid-anchored polyethylene glycol-1 is replaced by modified phospholipid-anchored polyethylene glycol-3.

[0076] Example 6

[0077] A hydroxy-α-sanshool lipid microbubble and a preparation method thereof. The specific implementation manner is the same as that of Example 1, except that an equal amount of modified phospholipid-anchored polyethylene glycol-1 is replaced by modified phospholipid-anchored polyethylene glycol-4.

[0078] Comparative Example 1

[0079] A hydroxy-α-sanshool lipid microbubble and a preparation method thereof. The specific implementation manner is the same as that of Example 1, except that an equal amount of polyethylene glycol-1 anchored by the modified phospholipid is replaced by polyethylene glycol monomethyl ether-2000-dioctadecylphosphatidylethanolamine.

[0080] Comparative Example 2

[0081] A hydroxy-α-sanshool lipid microbubble and a preparation method thereof, wherein the specific implementation manner is the same as that of Example 1, except that in step B3, the mass ratio of the water phase to the oil phase is 1:0.9.

[0082] Performance Testing

[0083] The hydroxy-α-sanshool lipid microbubbles obtained in the above-mentioned embodiments and comparative examples were tested for the following properties:

[0084] (1) Encapsulation efficiency: 0.015 g of hydroxy-α-sanshool lipid microbubbles (W) and 5 g of deionized water were placed in an ultrafiltration centrifuge tube and centrifuged at 3000 r / min for 15 min. The filtrate was collected and diluted to 10 mL with methanol. The concentration of hydroxy-α-sanshool in the filtrate was determined by HPLC (c 游离 ); Take 0.015g hydroxy-α-sanshool lipid microbubble and 5g methanol and stir for 30min, demulsify and dilute to 10mL, and use HPLC to determine the concentration of hydroxy-α-sanshool in the demulsified solution (c 总 ), the encapsulation efficiency and drug loading of hydroxy-α-sanshool lipid microbubbles were calculated according to the following formula:

[0085] Encapsulation efficiency (%) = [(c 总 -c 游离 ) / c 总 ]×100%;

[0086] Drug loading rate (%) = [(c 总 -c 游离 )×V / W]×100%.

[0087] The test results are shown in Table 1:

[0088] Table 1

[0089] Group Encapsulation rate% Drug loading rate % Example 1 98.1 3.87 Example 2 97.9 3.84 Example 3 97.8 3.81 Example 4 95.4 3.64 Example 5 94.3 3.45 Example 6 93.8 3.23 Comparative Example 1 90.2 2.51 Comparative Example 2 91.3 2.87

[0090] It can be seen from the data in Table 1 that the hydroxy-α-sanshool lipid microbubbles in Examples 1-3 of the present invention have a higher encapsulation rate and drug loading capacity; from the comparison between Examples 4 and 5 and Example 1, it can be seen that changing the ratio of bis(2-hydroxyethyl)amino(trihydroxymethyl)methane or the ratio of 1-bromopropane will hinder the formation of polyethylene glycol stereo brushes and reduce the encapsulation rate and drug loading rate of liposome microbubbles; from the comparison between Example 6 and Example 1, it can be seen that changing the number average molecular weight of polyethylene glycol-3 anchored by modified phospholipids will reduce its intermolecular force, which is not conducive to promoting The lipid shell microbubbles fuse with each other, thereby reducing the encapsulation rate and drug loading rate of the liposome microbubbles; from the comparison between Comparative Example 1 and Example 1, it can be seen that the use of polyethylene glycol monomethyl ether-2000-dioctadecylphosphatidylethanolamine instead of modified phospholipid-anchored polyethylene glycol-1 will reduce the intermolecular forces between the substances, thereby reducing the encapsulation rate and drug loading of the liposome microbubbles; from the comparison between Comparative Example 2 and Example 1, it can be seen that changing the ratio of the water phase and the oil phase will affect the formation of the water-in-oil system, thereby reducing the encapsulation rate and drug loading of the liposome microbubbles.

[0091] The above implementation modes are only for illustrating the technical concept and features of the present invention, and their purpose is to enable people familiar with this technology to understand the content of the present invention and implement it, and they cannot be used to limit the protection scope of the present invention. Any equivalent changes or modifications made according to the spirit of the present invention should be included in the protection scope of the present invention.

Claims

1. A hydroxy-α-sanshool lipid microbubble, characterized in that, The invention comprises the following raw materials in parts by weight: 8-12 parts of hydroxy-α-sanshool, 35-45 parts of lipid auxiliary materials, 5-10 parts of cholesterol, 7-10 parts of modified phospholipid-anchored polyethylene glycol, 20-22 parts of fluorine-containing inert gas, 70-110 parts of solvent and 120-220 parts of distilled water.

2. Hydroxy-α-sanshool lipid microvesicles according to claim 1, characterized in that, The lipid auxiliary material is one or more of soybean lecithin, distearoyl phosphatidylethanolamine and dipalmitoyl phosphatidylethanolamine.

3. Hydroxy-α-sanshool lipid microvesicles according to claim 1, characterized in that, The preparation method of the modified phospholipid-anchored polyethylene glycol comprises the following steps: A1. Add ethylene oxide, bis(2-hydroxyethyl)amino(trihydroxymethyl)methane, a catalyst and a solvent into a reaction vessel, react at 10-20°C for 3-4h, raise the temperature to 35-45°C, continue to react for 4-8h, evaporate the solvent and add it into anhydrous ether, filter and dry the precipitate to obtain modified polyethylene glycol; A2, adding the modified polyethylene glycol and toluene obtained in step A1 to a reaction vessel, stirring at room temperature for 20-30 min, adding carbonyldiimidazole, distearoylphosphatidylethanolamine and 4-dimethylaminopyridine, reacting at 55-65° C. for 6-7 h, rotary evaporating the solvent and adding to anhydrous ether, filtering and drying the precipitate to obtain phospholipid-anchored modified polyethylene glycol; A3. Add the phospholipid-anchored modified polyethylene glycol obtained in step A2, 1-bromopropane, ethyl acetate, N,N-dimethylformamide and 4-dimethylaminopyridine into a reaction vessel, heat to 70-90° C. and react for 5-7 hours. After the solvent is evaporated, add the mixture into anhydrous ether. Filter and dry the precipitate to obtain the modified phospholipid-anchored polyethylene glycol.

4. Hydroxy-α-sanshool lipid microbubble according to claim 3, characterized in that, The number average molecular weight of the modified phospholipid-anchored polyethylene glycol is 1500-2500.

5. Hydroxy-α-sanshool lipid microbubble according to claim 3, characterized in that, The mass ratio of the ethylene oxide to the bis(2-hydroxyethyl)amino(trihydroxymethyl)methane is 1:(0.15-0.2).

6. Hydroxy-α-sanshool lipid microbubble according to claim 3, characterized in that, The mass ratio of the phospholipid-anchored modified polyethylene glycol to 1-bromopropane in step A3 is 1:(0.04-0.08).

7. A method for preparing hydroxy-α-sanshool lipid microbubbles according to any one of claims 1 to 6, characterized in that: The following steps are involved: B1, dissolving hydroxy-α-sanshool, lipid auxiliary material and cholesterol in a solvent to obtain an oil phase; B2, dissolving the modified phospholipid-anchored polyethylene glycol in distilled water to obtain an aqueous phase; B3, the oil phase obtained in step B1 and the water phase obtained in step B2 are mixed, stirred at room temperature for 60-100 minutes, and then a fluorine-containing inert gas is introduced, and hydroxy-α-sanshool lipid microbubbles are obtained after washing and drying.

8. The method for preparing hydroxyl-α-sanshool lipid microbubbles according to claim 7, wherein The mass ratio of the water phase to the oil phase in step B3 is 1:(0.5-0.7).

9. The method for preparing hydroxyl-α-sanshool lipid microbubble according to claim 7, wherein The fluorine-containing inert gas is one or more of sulfur hexafluoride, perfluoroethane and perfluoropropane.

10. Use of the hydroxy-α-sanshool lipid microbubble described in any one of claims 1 to 6 or the hydroxy-α-sanshool lipid microbubble obtained by the preparation method described in claims 7 to 9, characterized in that: The amount of the hydroxy-α-sanshool lipid microbubble added to the external delayed spray is 0.2-0.4 wt %.

Citation Information

Patent Citations

  • Method for rapidly extracting different sanshool monomers

    CN113816870A

  • Hydroxyl-alpha-sanshool nano-liposome and preparation method thereof

    CN113975234A